COVID-X will fund EU Companies and Healthcare Providers to boost data-driven solutions with the power to overcome challenges in Diagnosis, Prognosis, and Follow-up. 

The funding is invested in products with TRL 7+ and [or in the process of] CE marking, covering two profiles:

1. Single players (EU Tech SMEs / Start-Ups) validating their solutions at one of COVID-X clinical partners;
2. Team players (Tech Provider working with a Healthcare provider that will validate the solution).

Apply by 16 September 2021. 

More information here